About us

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner, and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD.

For more information, please visit www.thermofisher.com

Get more with Patheon pharma services

About Patheon pharma services

Thermo Fisher Scientific provides industry-leading pharma services solutions for drug development, clinical trial logistics, and commercial manufacturing to customers through our Patheon brand. With more than 60 locations around the world, we provide integrated, end-to-end capabilities across all phases of development, including APIbiologicsviral vectors, cGMP plasmids, formulation, clinical trials solutions, logistics services, and commercial manufacturing, and packaging. Built on a reputation for scientific and technical excellence, we provide pharma and biotech companies of all sizes instant access to a global network of facilities and experts across the Americas, Europe, Asia, and Australia. We offer integrated drug development and clinical services tailored to fit your drug development journey through our Patheon™ Quick to Care™ program. Our Patheon™ Quick to Clinic™ programs for large and small molecules help you balance speed and risk during early development so you can file your Investigational New Drug Application (IND) quickly and successfully. Digital innovations such as our mysupply Platform and Pharma 4.0 enablement offer real-time data and a streamlined experience. Together with our customers, we’re rapidly turning pharmaceutical possibilities into realities.

Our commitment to supplier diversity

Our Supplier Diversity Program provides qualified certified small and diverse businesses with opportunities to become a preferred vendor for Thermo Fisher Scientific. We recognize the importance of valuing the diversity of our employees and all whom we do business with, is an integral element of our corporate culture. We are committed to ensuring that we embed an inclusive culture in all our business practices and actively seek to maximize business opportunities for certified small and diverse businesses. Learn more about Thermo Fisher’s Supplier Diversity Program

Recognitions and awards

We are honored to receive awards throughout our history that recognize our commitment to our customers. From our scientists and engineers to our line operators and business professionals, we take our work personally, constantly striving to become a better partner to those creating life-saving treatments. 

 2021 Winner
CMO Leadership Award

Capabilities (Overall, Big Pharma, Small Pharma) Compatibility (Overall, Big Pharma, Small Pharma) Expertise (Overall, Big Pharma, Small Pharma) Quality (Overall, Big Pharma, Small Pharma) Reliability (Overall, Big Pharma, Small Pharma)

IndustryWeek Best Plants Award for our Greenville, NC, site
 2020 Winner
CMO Leadership Award

Capabilities (Overall, Big Pharma, Small Pharma) Compatibility (Overall, Big Pharma, Small Pharma) Expertise (Overall, Big Pharma, Small Pharma) Quality (Overall, Big Pharma, Small Pharma) Reliability (Overall, Big Pharma, Small Pharma) 

 2019 Winner
CMO Leadership Award

Reliability (Small Pharma) 

 2018
Best International CMO in Asia award at the Biomanufacturing Asia 2018 Conference
 
 2017
NC State Poole College of Management Employer of the Year
Supply Chain Resiliency Partner of the Year by the Global Supply Chain Resiliency Council
 
 2016
CMO Leadership Awards Ceremony Recognotion in the areas of:
  • Quality (Overall)

  • Quality (Small Pharma)

  • Reliability (Small Pharma)

  • Capabilities (Small Pharma)

  • Expertise (Small Pharma)

  • Compatibility (Small Pharma)

World Class Supplier Annual Award and 2016 Best Overall Performance of External Party Award from Merck
 
 2015
Our cGMP facility in Brisbane, Australia, won the Frost and Sullivan Best Practices Award for CMO of the Year, APAC region We received an award at the CMO Leadership Awards Ceremony for achievements in innovation
We received the Excellence in Service & Supply Award from Merck
 
 2014
Our cGMP facility in Brisbane, Australia, won the Frost and Sullivan Best Practices Award for CMO of the Year, APAC region We received an award at the CMO Leadership Awards Ceremony for achievements in innovation
We received the Excellence in Service & Supply Award from Merck
 
 2013
Greenville, NC, site named Amgen’s 2013 Manufacturing Site of the Year
CMO Leadership Awards Ceremony recognition in the areas of quality, reliability, innovation, and productivity
 
 2012
European Outsourcing Award—Most Effective Process Development/Scale-up Program
CMO Leadership Awards Ceremony recognition in the areas of quality, reliability, innovation, and productivity
 
 2011
European Outsourcing Award in the Best New Product Category
CMO Leadership Awards Ceremony recognition in the areas of quality, reliability, innovation, and productivity
 
 2010
Lilly Sustained Supplier Award
Ranked as top CMO by PharmSource® based on the number of FDA approvals 2010 European Outsourcing Award—Best Tech Transfer Category 

 

Assurance of quality 

Success in business is based on trust, especially in pharmaceuticals. By putting quality at the core of everything we do, Patheon pharma services has earned the trust of clients around the world—and those companies in turn have secured the trust of patients. Trust has been earned through regulatory compliance, exceptional Right First Time/On-Time performance, and safe and effective products. While our ability to generate time and cost efficiencies has earned us business from every corner of the industry, it is our uncompromising quality that continues to build our client relationships and strategic partnerships. We pursue improvement in every functional area of the business, proactively seek out opportunities to prevent problems before they occur, and continuously examine and refine systems and processes. Our ultimate objective is for the pharmaceutical to be of the highest quality possible when it reaches the patient.


More than 

2,600

regulatory and client
inspections since 2005 

More than 

2,600

regulatory and client
inspections since 2005 

 

Our track record

In an industry where quality is the bottom line, we welcome the opportunity to meet the high standards of our clients and regulatory bodies around the world. Since 2005, our facilities have undergone more than 2,600 regulatory and client inspections. Patheon pharma services has also had 33 Pre-Approval Inspections (PAIs) waived by the FDA in the past 10 years. 


Global environmental, health, and safety

Pharmaceuticals, especially highly potent compounds, require strict adherence to regulations and safety practices. We are committed to the health and safety of our employees and the protection of the environment. We comply with evolving regulations and use progressive modernization to mitigate risk for people and the planet. Our company culture is one of prevention, compliance, and improvement. We identify and adopt industry best practices, not only to promote safety, but also to protect against costly delays. We reinforce these efforts through continuous investments in the latest equipment and processes across our global network. See additional details about our Environmental, Health & Safety program and its goals. 


Clients we serve 

Emerging pharma and biotech 

We understand the unique challenges faced by emerging pharmaceutical and biotech companies, including funding constraints, intense time pressures, and the need to build experience and resources beyond the discovery phase. Every day we help remove the barriers that stand between exciting, new discoveries and the patients who need them. We provide instant access to comprehensive capabilities for drug development, clinical trial logistics, and commercial manufacturing of both large and small molecule drug substances and drug products across a wide range of finished dosage forms, including oral solid dose, sterile injectables, and softgels, as well as cell and gene therapies. We bring formulation and process development expertise to pursue early-phase goals and establish a scientifically sound foundation for success in later stages and beyond. What’s more, we’ve created unique solutions dedicated to helping small companies at every turn on their path to market.

... Read more

We take pride in being able to meet you not only where you are on the road from drug development to commercialization but also where you are in the world. We have a global network of more than 60 locations across 23 countries, including state-of-the-art development and manufacturing facilities throughout North America, Europe, Asia, and Oceania. Since 2010, we have also maintained a presence in Latin America, where our sites in Argentina, Brazil, Chile, Colombia, Mexico, and Peru provide labeling, secondary packaging, distribution, and logistics services, and we are able to offer Importer of Record (IoR) services. We also have facilities in South Africa, India, and Russia. While our team is truly global, we take pride in our ability to serve you locally. What’s more, our support doesn’t end with our CDMO services. We are backed by the entire Thermo Fisher Scientific network, which enables us to support you with a spectrum of solutions, from lab equipment and instruments, to chemicals and scientific supplies, to enterprise services and digital solutions.

... Read less

Midsize pharma

Many of our midsize clients are transforming the way pharmaceuticals are developed and commercialized with a new vision for their business model. Patheon pharma services is their means to turn that vision into reality. Many midsize companies can benefit from a virtual model with ready access to world-class facilities, technologies, talent, and quality to build highly customized development and manufacturing solutions. This outsourced model provides the agility to quickly scale up or down in response to market conditions, enabling companies to have a lean infrastructure and to focus on their core strengths in discovery and marketing. This model keeps midsized firms from becoming mired in an overly complex supply chain of multiple specialized vendors. We can offer these companies a strategic partnership with our end-to-end capabilities taking their discovery all the way from the lab bench to the patient bedside. 

Large pharma

Capacity. Responsiveness. Reliable quality. Those are just three of the reasons that the world’s top 20 pharmaceutical companies put their trust in our drug development and commercial manufacturing expertise. For more than 40 years, we have helped large pharma to manage the ups and downs of demand, mitigate risk with redundant resources, and take advantage of opportunities in markets around the globe. As a strategic partner to the industry’s leaders, we offer innovative solutions that preserve capital and in- house resources, freeing our clients to focus on what they do best. 

Generic pharma (OTC)

As generic opportunities grow increasingly complex, we offer the technical expertise, capacity, and agility to capitalize on opportunities. With state-of- the-art facilities, reliable on-time performance, and industry-leading regulatory compliance, we meet strict timelines and provide a dependable, high-quality supply.